Effect of P-glycoprotein on the ocular disposition of a model substrate, quinidine

References

• Ambudkar SV, Dey S, Hrycyna CA, Ramachandra M, Pastan I, Gottesman MM. Biochemical, cellular, and phar- macological aspects of the multidrug transporter. Annu Rev Pharmacol ToxicoL 1999;39:361–398.
   PubMed Web of Science ®Google Scholar
• Matheny CJ, Lamb MW, Brouwer KR, Pollack GM. Phar-macokinetic and pharmacodynamic implications of P-glycoprotein modulation. Pharmacotherapy. 2001 ;21 : 778–796.
   PubMed Web of Science ®Google Scholar
• Sikic BI, Fisher GA, Lum BL, Halsey J, Beketic-Oreskovic L, Chen G. Modulation and prevention of multidrug resis-tance by inhibitors of P-glycoprotein. Cancer Chemother Pharmacol. 1997;40 Suppl: S13–S19.
   Google Scholar
• Kajikawa T, Mishima HK, Murakami T, Takano M. Role of P-glycoprotein in distribution of rhodamine 123 into aqueous humor in rabbits. Curr Eye Res. 1999;18:240–246.
   PubMed Web of Science ®Google Scholar
• Greenwood J. Characterization of a rat retinal endothelial cell culture and the expression of P-glycoprotein in brain and retinal endothelium in vitro. J Neuroimmuna 1992;39:123–132.
   PubMed Web of Science ®Google Scholar
• Kennedy BG, Mangini NJ. P-glycoprotein expression in human retinal pigment epithelium. Mo/ Vis. 2002;8:422–430.
   PubMed Web of Science ®Google Scholar
• Cunha-Vaz JG. The blood-retinal barriers. Doc Ophthal-mol. 1976;41:287–327.
   PubMed Web of Science ®Google Scholar
• Cunha-Vaz JG. The blood-ocular barriers: Past, present, and future. Doc Ophthalmol. 1997;93:149–157.
   PubMed Web of Science ®Google Scholar
• Cunha-Vaz JG. Blood-retinal barriers in health and disease. Trans Ophthalmol Soc UK. 1980;100:337–340.
   PubMedGoogle Scholar
• Ito A, Yamaguchi K, Onogawa T, Unno M, Suzuki T, Nishio T, Sasano H, Abe T, Tamai M. Distribution of organic anion-transporting polypeptide 2 (oatp2) and oatp3 in the rat retina. Invest Ophthalmol Vis Sci. 2002;43: 858–863.
   Google Scholar
• Holash JA, Stewart PA. The relationship of astrocyte-like cells to the vessels that contribute to the blood-ocular bar-riers. Brain Res. 1993;629:218–224.
   PubMed Web of Science ®Google Scholar
• Hirrlinger J, Konig J, Dringen R. Expression of mRNAs of multidrug resistance proteins (Mrps) in cultured rat astro-cytes, oligodendrocytes, microglial cells and neurones. J Neurochem. 2002;82:716–719.
   Google Scholar
• Miller MH, Madu A, Samathanam G, Rush D, Madu CN, Mathisson K, Mayers M. Fleroxacin pharmacokinetics in aqueous and vitreous humors determined by using com-plete concentration-time data from individual rabbits. Antimicrob Agents Chemother. 1992;36:32–38.
   Google Scholar
• Mayers M, Rush D, Madu A, Motyl M, Miller MH. Phar-macokinetics of amikacin and chloramphenicol in the aqueous humor of rabbits. Antimicrob Agents Chemother. 1991;35:1791–1798.
   Google Scholar
• Robinson JE. Microdialysis: A novel tool for research in the reproductive system. Biol Reprod. 1995;52:237–245.
   PubMed Web of Science ®Google Scholar
• Maggs DG, Borg WP, Sherwin RS. Microdialysis tech-niques in the study of brain and skeletal muscle. Dia-betologia. 1997;40 Suppl 2:S75–S82.
   Google Scholar
• Bito L, Davson H, Levin E, Murray M, Snider N. The con-centrations of free amino acids and other electrolytes in cerebrospinal fluid, in vivo dialysate of brain, and blood plasma of the dog. J Neurochem. 1966;13:1057–1067.
   Google Scholar
• Macha S, Mitra AK. Ocular pharmacokinetics in rabbits using a novel dual probe microdialysis technique. Exp Eye Res. 2001;72:289–299.
   PubMed Web of Science ®Google Scholar
• Demeule M, Jodoin J, Beaulieu E, Brossard M, Beliveau R. Dexamethasone modulation of multidrug transporters in normal tissues. FEBS Lett. 1999;442:208–214.
   Google Scholar
• Macha S, Mitra AK. Ocular pharmacokinetics of cephalosporins using microdialysis. J Ocul Pharmacol Ther. 2001;17:485–498.
   PubMed Web of Science ®Google Scholar
• Llopis J, Kass GE, Duddy SK, Farell GC, Gahm A, Orrenius S. Mobilization of the hormone-sensitive calcium pool increases hepatocyte tight junctional permeability in the perfused rat liver. FEBS Lett. 1991;280:84–86.
   PubMed Web of Science ®Google Scholar
• Knudsen LL, Dissing T, Hansen MN, Nielsen-Kudsk E Ocular fluorescein kinetics before and after vitrectomy on swine. Graefe's Arch Clin Exp OphthalmoL 2001;239: 832–839.
   PubMed Web of Science ®Google Scholar
• Knudsen LL, Olsen T, Nielsen-Kudsk F. Anterior chamber fluorescein kinetics compared with vitreous kinetics in normal subjects. Acta Ophthalmol Scand. 1998;76:561–567.
   Google Scholar
• Larsen M, Loft S, Hommel E, Lund-Andersen H. Fluores-cein and fluorescein glucuronide in plasma after intra-venous injection of fluorescein. Acta Ophthalmol (Copenh). 1988;66:427–432.
   Google Scholar
• Ueda CT, Nickols JG. Comparative pharmacokinetics of quinidine and its O-desmethyl metabolite in rabbits. J Pharm Sci. 1980;69:1400–1403.
   PubMed Web of Science ®Google Scholar
• Rittenhouse KD, Peiffer RL, Jr., Pollack GM. Evaluation of microdialysis sampling of aqueous humor for in vivo models of ocular absorption and disposition. J Pharm Biomed AnaL 1998;16:951–959.
   Google Scholar
• Broxterman HJ, Giaccone G, Lankelma J. Multidrug resis-tance proteins and other drug transport-related resistance to natural product agents. Curr Opin OncoL 1995;7:532–540.
   Google Scholar
• Kusuhara H, Suzuki H, Terasaki T, Kakee A, Lemaire M, Sugiyama Y. P-Glycoprotein mediates the efflux of quini-dine across the blood-brain barrier. J Pharmacol Exp Ther. 1997;283:574–580.
   PubMed Web of Science ®Google Scholar
• Matsuoka Y, Okazaki M, Kitamura Y, Taniguchi T. Devel-opmental expression of P-glycoprotein (multidrug resis-tance gene product) in the rat brain. J NeurobioL 1999;39:383–392.
   PubMed Web of Science ®Google Scholar